Erythromycin Lactobionate Injection Shortage
Last Updated: May 15, 2025
Status: Current
Products Affected - Description
-
- Erythrocin powder for solution for injection, Pfizer, 500 mg, vial, 10 count, NDC 00409-6482-01
Reason for the Shortage
-
- Nexus has 500 mg vials available.
- Pfizer has Erythrocin on shortage due to manufacturing delays.
Available Products
-
- Erythrocin powder for solution for injection, Pfizer, 500 mg, ADD-Vantage vial, 10 count, NDC 00409-6476-44
- Erythromycin Lactobionate powder for solution for injection, Nexus Pharmaceuticals, 500 mg, vial, 10 count, NDC 14789-0116-05
Estimated Resupply Dates
-
- Pfizer has short-dated Erythrocin 500 mg vials available in limited supply with an expiration date of July 2025. The company estimates a release date of September 2025 for vials with regular dating.
Updated
Updated May 15, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 21, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.